Please assess the completion status of the following clinical trial:

Trial Title: Bispectral Index-Guided Versus Fixed Dose Administration of Desflurane During Balanced Anesthesia With Remifentanil

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients scheduled for operation under balanced anesthesia using desflurane and remifentanil~Exclusion Criteria:~* Refusal of consent~* General anesthesia with agents other than desflurane and remifentanil~* Patients with allergy to neuromuscular blocker, volatile anesthetics, opioids~* History of malignant hyperthermia~* Patients taking CNS stimulants~* Chronic alcohol abuser~* Patients with severe depressed left ventricular function, EF \< 30%~* Patients with convulsive disorders~* ASA class IV, V, VI~* Patients with systolic arterial blood pressure lower than 90mmHg before surgery~* Patients needing inotropic infusion during surgery~* Anesthesia time less than 30 minutes

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Administering desflurane according to the patient's BIS value (Type: EXPERIMENTAL): The anesthesiologist administers the volatile anesthetic desflurane to set the patient's BIS value at 50 during balanced anesthesia, and titrate the remifentanil dose to set the patient's systolic arterial blood pressure between 100-140mmHg.
- Administering desflurane at 1 MAC (Type: EXPERIMENTAL): The anesthesiologist administers the volatile anesthetic desflurane at 1 MAC during balanced anesthesia, and titrate the remifentanil dose to set the patient's systolic arterial blood pressure between 100-140mmHg.

Based on this trial design, predict the completion outcome and termination type (if applicable).